John Nolen
Family Medicine · Springdale, ARNPI 1649213083
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.6% of the total across 440 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 39 manufacturers, the largest accounting for just 12.2% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,707 and has fallen 78.8% since, to $361 in 2023.
Across 440 payments — averaging $13.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$711
- Lilly USA, LLC$672
- AbbVie$393
- Johnson & Johnson$387
- AstraZeneca$378
- Takeda Pharmaceuticals U.S.A., Inc.$349
- plus $3K from 33 others
What the payments were for
- Food & beverage$5,813100%
- Education$210%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 52 | $711 |
| Lilly USA, LLC | 54 | $672 |
| AbbVie(2 entities) | 26 | $393 |
| Johnson & Johnson | 40 | $387 |
| AstraZeneca | 23 | $378 |
| Takeda Pharmaceuticals U.S.A., Inc. | 27 | $349 |
| Merck | 26 | $330 |
| Amgen(2 entities) | 17 | $321 |
| Pfizer | 32 | $316 |
| Abbott | 14 | $238 |
| Supernus Pharmaceuticals, Inc. | 13 | $196 |
| Astellas Pharma US Inc | 14 | $192 |
| Bayer | 12 | $168 |
| Biohaven Pharmaceutical Holding Company Ltd. | 18 | $146 |
| GSK | 9 | $126 |
| Esperion Therapeutics, Inc. | 9 | $121 |
| Boehringer Ingelheim | 6 | $93 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $72 |
| Biohaven Pharmaceuticals, Inc. | 5 | $67 |
| Sanofi-aventis U.S. LLC | 5 | $61 |
| Teva Pharmaceuticals USA, Inc. | 4 | $48 |
| Alfasigma USA, Inc. | 3 | $44 |
| Avanir Pharmaceuticals, Inc. | 3 | $40 |
| Eisai Inc. | 3 | $39 |
| Mylan Specialty L.p. | 3 | $35 |
| Kyowa Kirin, Inc. | 2 | $33 |
| Genentech USA, Inc. | 2 | $30 |
| Ironshore Pharmaceuticals Inc. | 2 | $28 |
| Dexcom, Inc. | 2 | $27 |
| Corium, LLC | 1 | $24 |
| Gilead | 1 | $23 |
| Arbor Pharmaceuticals, Inc. | 1 | $21 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Boston Scientific | 1 | $19 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Ironwood Pharmaceuticals, Inc | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $14 |
| Novartis | 1 | $12 |
| Currax Pharmaceuticals LLC | 1 | $11 |
How this compares
$5,834 in reported general payments places this provider in the 85th percentile of 1,347 family medicine providers in Arkansas.
Other family medicine in Springdale
- Kent CovertSpringdale$11K
- Glenn GibbonsFort Smith$179K
- Hetal PatelParagould$147K
- David GersonSherwood$119K
- Scott MusickBentonville$102K
- Broderick EatonWynne$49K
- Craig LevoyBentonville$30K
- Allen BeachyFort Smith$21K
- Hunter CarringtonHot Springs$20K
- Harold BettonLittle Rock$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.